» Articles » PMID: 21668741

Individual Differences in Morphine and Butorphanol Analgesia: a Laboratory Pain Study

Overview
Journal Pain Med
Date 2011 Jun 15
PMID 21668741
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Responses to opioid analgesics are highly variable, and the understanding of contributing factors is limited. This laboratory study was designed to examine the contributions of sex and race to inter-individual variability in response to opioids.

Design: A randomized, double-blind, mixed design was implemented in the evaluation of analgesic response to a µ-opioid agonist and mixed agonist-antagonist, using three well-validated experimental pain assays (thermal, pressure, and ischemic).

Subjects: Participants included a total of 142 healthy subjects (76 men/66 women), 119 non-Hispanic whites and 23 African Americans.

Intervention: Three sessions of pain testing were completed prior to and following an intravenous administration of morphine (0.08 mg/kg), butorphanol (0.016 mg/kg), and placebo (saline) in counterbalanced order.

Outcome Measures: A change score was calculated from the difference between the pre-drug and postdrug values. Three separate change scores (morphine, saline, and butorphanol) were computed for each experimental pain variable. Mixed-model analyses of covariance were performed on analgesic change scores.

Results: Significant sex differences emerged for predrug pain measures with minimal differences for race. Sex differences in opioid analgesia were not demonstrated. However, significant race differences and race X drug interactions emerged for thermal, pressure, and ischemic pain measures. The pattern of results generally indicated that for pressure and ischemic pain, African American subjects showed greater analgesic responses to both medications compared with non-Hispanic whites. For thermal pain threshold, butorphanol but not morphine analgesia was greater for African American vs non-Hispanic whites.

Conclusions: Findings are among the first to demonstrate race differences in a laboratory study of opioid analgesia.

Citing Articles

Sex Differences in Pain Sensitivity in a Dutch Cohort: Cross-Sectional and Web-Based Multidimensional Study.

Smits R, van der Wal S, van Boekel R, Timmerman H, Bronkhorst E, Abrar D J Med Internet Res. 2024; 26:e53926.

PMID: 39121479 PMC: 11344183. DOI: 10.2196/53926.


Gender Differences in Pain Threshold, Unpleasantness, and Descending Pain Modulatory Activation Across the Adult Life Span: A Cross Sectional Study.

Failla M, Beach P, Atalla S, Dietrich M, Bruehl S, Cowan R J Pain. 2023; 25(4):1059-1069.

PMID: 37956742 PMC: 10960699. DOI: 10.1016/j.jpain.2023.10.027.


The effects of fentanyl, oxycodone, and butorphanol on gastrointestinal function in patients undergoing laparoscopic hysterectomy: a prospective, double-blind, randomized controlled trial.

Guo M, Liu S, Gao J, Han C, Yang C, Liu C BMC Anesthesiol. 2022; 22(1):53.

PMID: 35209847 PMC: 8867837. DOI: 10.1186/s12871-022-01594-9.


Influences of Gender on Intravenous Nalbuphine Actions After Major Abdominal Surgery: A Multicenter Study.

Ayad A, Salman O, Ibrahim A, Al-Taher W, Mishriky A, Pergolizzi J Pain Ther. 2021; 10(2):1215-1233.

PMID: 34110603 PMC: 8586316. DOI: 10.1007/s40122-021-00277-6.


Strategies for Developing Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects.

Paton K, Atigari D, Kaska S, Prisinzano T, Kivell B J Pharmacol Exp Ther. 2020; 375(2):332-348.

PMID: 32913006 PMC: 7589957. DOI: 10.1124/jpet.120.000134.


References
1.
Cepeda M, Farrar J, Roa J, Boston R, Meng Q, Ruiz F . Ethnicity influences morphine pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther. 2001; 70(4):351-61. View

2.
Zun L, Downey L, Gossman W, Rosenbaumdagger J, Sussman G . Gender differences in narcotic-induced emesis in the ED. Am J Emerg Med. 2002; 20(3):151-4. DOI: 10.1053/ajem.2002.32631. View

3.
Tamayo-Sarver J, Hinze S, Cydulka R, Baker D . Racial and ethnic disparities in emergency department analgesic prescription. Am J Public Health. 2003; 93(12):2067-73. PMC: 1448154. DOI: 10.2105/ajph.93.12.2067. View

4.
Mague S, Blendy J . OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug Alcohol Depend. 2010; 108(3):172-82. PMC: 2887703. DOI: 10.1016/j.drugalcdep.2009.12.016. View

5.
Beth Mechlin M, Maixner W, Light K, Fisher J, Girdler S . African Americans show alterations in endogenous pain regulatory mechanisms and reduced pain tolerance to experimental pain procedures. Psychosom Med. 2005; 67(6):948-56. DOI: 10.1097/01.psy.0000188466.14546.68. View